Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
papaverine camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10a small molecule NA drugbank Vascular constriction (function)[MeSHID:D014661]
Erectile dysfunction[MeSHID:D007172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Spasm[MeSHID:D013035]
Muscle Cramp[MeSHID:D009120]
NA approved,investigational inhibitor
papaverine camp-specific 3',5'-cyclic phosphodiesterase 4b small molecule NA drugbank , DGIDB Vascular constriction (function)[MeSHID:D014661]
Erectile dysfunction[MeSHID:D007172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Spasm[MeSHID:D013035]
Muscle Cramp[MeSHID:D009120]
0.77 approved,investigational inhibitor
papaverine phosphodiesterase 4d NA Successful target TTD , DGIDB Vascular constriction (function)[MeSHID:D014661]
Erectile dysfunction[MeSHID:D007172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Spasm[MeSHID:D013035]
Muscle Cramp[MeSHID:D009120]
0.14 approved unknown
papaverine phosphodiesterase 5a NA Successful target TTD , DGIDB Vascular constriction (function)[MeSHID:D014661]
Erectile dysfunction[MeSHID:D007172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Spasm[MeSHID:D013035]
Muscle Cramp[MeSHID:D009120]
0.18 approved unknown
click here to return to the previous page